Patients with untreated prolactinomas were shown to have higher serum insulin and homeostasis model assessment insulin resistance (HOMA-IR), as well as lower adiponectin levels [8] and impaired glucose tolerance [9] compared to controls. Here, INS is linked to Insulin resistance.